Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine).
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine).
Disclosures can be found at Neurology.org).
